A specific protocol of autologous bone marrow concentrate and platelet products versus exercise therapy for symptomatic knee osteoarthritis: a randomized controlled trial with 2 year follow-up

Table 3 Exercise therapy versus BMC treatment 3-month changes on outcome measures

Metric	Group	N	3-month change score	p-value
VAS (mm)	Exercise	22	− 8	0.40
VAS (mm)	BMC	24	− 12.5	0.40
LEAS	Exercise	21	− 1.1	0.002
LEAS	BMC	24	0.8	0.002
KSS—knee score	Exercise	22	0.6	< 0.001
KSS—knee score	BMC	23	12.0	< 0.001
KSS—function score	Exercise	22	2.3	0.17
KSS—function score	BMC	24	7.5	0.17
SF-12 physical	Exercise	22	2.4	0.27
SF-12 physical	BMC	24	4.9	0.27
SF-12 mental	Exercise	22	− 1.5	0.68
SF-12 mental	BMC	24	− 2.4	0.68
ROM (degrees)	Exercise	22	2.6	0.97
ROM (degrees)	BMC	23	2.6	0.97

ISSN: 1479-5876